Based on the information available, there are no specific vaccines that have been identified as problematic when using Cosentyx (secukinumab) [1]. However, it is always recommended to consult with a healthcare provider before receiving any vaccinations while on a biologic medication like Cosentyx [1].

Biologic medications, such as Cosentyx, work by targeting specific parts of the immune system [1]. Therefore, there may be a theoretical risk of reduced vaccine effectiveness or increased risk of adverse reactions when receiving live vaccines [1]. However, there is no specific information regarding which vaccines to avoid when using Cosentyx [1].

It is important to note that the Centers for Disease Control and Prevention (CDC) recommends that individuals on biologic therapy, like Cosentyx, receive inactivated or non-live vaccines at least two weeks prior to starting the biologic therapy [1]. This recommendation is due to the potential for reduced vaccine effectiveness or increased risk of adverse reactions when receiving live vaccines [1].

In summary, while there are no specific vaccines to avoid when using Cosentyx, it is recommended to consult with a healthcare provider before receiving any vaccinations while on this medication. Additionally, it is recommended to receive any necessary inactivated or non-live vaccines at least two weeks prior to starting Cosentyx [1].

Sources:
[1] DrugPatentWatch.com. (n.d.). Secukinumab (Cosentyx). Retrieved from <https://www.drugpatentwatch.com/drugs/cosentyx>